Related Experiment Video
Updated: Jan 29, 2026
09:30
Detection of Functional Matrix Metalloproteinases by Zymography
Published on: November 8, 2010
84.9K
Design and Structural Evolution of Matrix Metalloproteinase Inhibitors
Thomas Fischer1, Nicole Senn1, Rainer Riedl1
1Center of Organic and Medicinal Chemistry, Institute of Chemistry, and Biotechnology, Zurich University of Applied Sciences (ZHAW), Einsiedlerstrasse 31, 8820, Wädenswil, Switzerland.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|February 6, 2019
Summary
Matrix metalloproteinases (MMPs) are key targets for severe diseases. Novel small-molecule inhibitors, guided by structural data, show improved affinity and selectivity, paving the way for clinical use.
Area of Science:
- Biochemistry and Medicinal Chemistry
- Drug Discovery and Development
Background:
- Matrix metalloproteinases (MMPs) are implicated in numerous severe diseases.
- Despite being recognized as druggable targets, previous MMP inhibitor drug-discovery programs have yielded limited clinical success.
Purpose of the Study:
- To review the structural evolution of small-molecule matrix metalloproteinase inhibitors.
- To highlight novel chemical entities with enhanced affinity and selectivity profiles.
- To underscore the role of structure-based design in developing inhibitors for challenging drug targets.
Main Methods:
- Analysis of X-ray crystallographic data for protein targets and inhibitor cocrystal structures.
- Examination of the structural diversity and evolutionary trajectory of small-molecule MMP inhibitors.
Main Results:
- Significant advancements in the structural design of small-molecule MMP inhibitors have been achieved.
- Novel inhibitors exhibit improved affinity and selectivity, addressing previous limitations.
- Structure-based design strategies have proven effective in optimizing inhibitor properties.
Conclusions:
- The latest structural evolution of MMP inhibitors offers promising therapeutic potential.
- Improved inhibitor design strategies pave the way for clinical application of MMP modulators.
- Structure-based design is a powerful technique for developing treatments for challenging drug targets.
Keywords:
drug desgindrug discoveryinhibitorsmedicinal chemistrymetalloenzymesstructure-activity relationshipsMore Related Videos
Related Concept Videos
02:55The Evidence for Evolution
48.0K
Genetic variations accumulating within populations over generations give rise to biological evolution. Evolutionary changes can result in the formation of novel varieties and entire new species. These changes are responsible for the diverse forms of life inhabiting the planet. The evidence for evolution suggests that all living organisms descended from common ancestors.
48.0K
01:54Convergent Evolution
32.8K
Evolution shapes the features of organisms over time, ensuring that they are suited for the environments in which they live. Sometimes, selection pressure leads to the rise of similar but unrelated adaptations in organisms with no recent common ancestors, a process known as convergent evolution.
32.8K
01:28Structure-Activity Relationships and Drug Design
1.8K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.8K
01:52Eukaryotic Transcription Inhibitors
11.0K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.0K
02:01Group Design
10.4K
The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between...
10.4K
01:24Eukaryotic Evolution
40.9K
The endosymbiont theory is the most widely accepted theory of eukaryotic evolution; however, its progression is still somewhat debated. According to the nucleus-first hypothesis, the ancestral prokaryote first evolved a membrane to enclose DNA and form the nucleus. Conversely, the mitochondria-first hypothesis suggests that the nucleus was formed after endosymbiosis of mitochondria.
Contrary to the endosymbiont theory, the eukaryote-first hypothesis proposes that the simpler prokaryotic and...
Contrary to the endosymbiont theory, the eukaryote-first hypothesis proposes that the simpler prokaryotic and...
40.9K